ZIMMER BIOMET HOLDINGS, INC.

LISTEDNYSE

SYMBOLZBH

SIC3842

STATE OF INC.DE

FISCAL YEAR ENDSDecember 31

CIK1136869

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)	Amount	%
Total debt	7,519	37.2
Stockholders' equity	12,698	62.8
Total capitalization	20,217	100.0

190,737,689 shares outstanding at 30 July 2026 (cover page of the 10-Q filed 5 August 2026).

LONG-TERM DEBT 12/31/25

($ millions)	Amount
Long-term debt, noncurrent	6,932
Current maturities	587

CAPITAL STOCK 12/31/25

Common shares authorized	1,000,000,000
Common shares issued	318,700,000
Treasury shares	123,200,000
Par or stated value per share ($)	0.01
Outstanding at 7/30/26	190,737,689

DIVIDENDS DECLARED/PAID

Fiscal year	Per share $	Payout %
2025	0.96	27.0
2024	0.96	21.7
2023	0.96	19.7
2022	0.96	87.3
2021	0.96	50.3

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware. Formerly known as ZIMMER HOLDINGS INC (to 8 June 2015).

BUSINESS: Classified by the SEC under Standard Industrial Classification 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. Large accelerated filer. Principal executive office: 345 East Main Street, Warsaw, IN 46580. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)	12/31/25	12/31/24	12/31/23
Revenues	8,232	7,679	7,394
Cost of revenues	2,494	2,191	2,084
Research and development	458	437	459
Selling, general and administrative	3,257	2,930	2,839
Depreciation and amortization	1,094	996	952
Operating income	1,098	1,286	1,278
Income before income taxes	831	1,037	1,067
Income taxes	126	131	42
Net income	705	904	1,024
Earned per share, diluted ($)	3.55	4.43	4.88
Dividends per share ($)	0.96	0.96	0.96

CONSOLIDATED BALANCE SHEET

($ millions)	12/31/25	12/31/24
Cash and equivalents	592	526
Receivables, net	1,704	1,481
Inventories	2,286	2,235
Total current assets	5,120	4,672
Property, plant and equipment, net	2,207	2,049
Goodwill	9,947	8,951
Total assets	23,092	21,365
Total current liabilities	2,584	2,451
Long-term debt	6,932	5,342
Total liabilities	10,386	8,889
Stockholders' equity	12,698	12,468
Total liabilities and equity	23,092	21,365

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year ended	Revenues	Oper. income	Net income	Net margin %	EPS diluted $	Div. per share $	Oper. cash flow	Capital expend.	Free cash flow	Total assets	Total liabilities	Total debt	Stockholders' equity	ROE %	Debt / equity
12/31/25	8,232	1,098	705	8.6	3.55	0.96	1,697	224	1,473	23,092	10,386	7,519	12,698	5.6	0.59
12/31/24	7,679	1,286	904	11.8	4.43	0.96	1,499	204	1,296	21,365	8,889	6,205	12,468	7.2	0.50
12/31/23	7,394	1,278	1,024	13.8	4.88	0.96	1,582	291	1,290	21,497	9,009	5,800	12,480	8.2	0.46
12/31/22	6,940	696	231	3.3	1.10	0.96	1,356	188	1,168	21,066	9,039	5,700	12,020	1.9	0.47
12/31/21	6,827	860	402	5.9	1.91	0.96	1,499	144	1,356	23,456	10,790	1,000	12,661	3.2	0.08
12/31/20	6,128	83	(139)	-2.3	(0.67)	0.96	1,204	112	1,093	24,418	12,218	8,100	12,194	-1.1	0.66
12/31/19	7,982	1,138	1,132	14.2	5.47	0.96	1,586	207	1,379	24,639	12,246	8,200	12,388	9.1	0.66
12/31/18	7,933	34	(379)	-4.8	(1.86)	0.96	1,747	163	1,585	24,127	12,851	8,939	11,271	-3.4	0.79
12/31/17	7,803	799	1,814	23.2	8.90	0.96	1,582	156	1,426	26,014	14,278	10,142	11,736	15.5	0.86
12/31/16	7,668	821	306	4.0	1.51	0.96	1,632	185	1,448	26,684	17,014	11,241	9,669	3.2	1.16

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

ZIMMER BIOMET HOLDINGS, INC.
CIK 1136869 · EIN 13-4151777

PRINCIPAL OFFICE:

345 East Main Street, Warsaw, IN 46580
Tel.: 5742676131

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 20 February 2026

FORMER NAMES:

ZIMMER HOLDINGS INC

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

9/8/26	8-K	period 9/8/26
8/5/26	8-K	period 8/5/26
8/5/26	10-Q	period 6/30/26
8/5/26	8-K	period 8/5/26
6/29/26	8-K	period 6/26/26
5/27/26	8-K	period 5/22/26
5/12/26	8-K	period 5/12/26
5/1/26	10-Q	period 3/31/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/20/26) · 10-K FY2024 (filed 2/25/25) · 10-K FY2023 (filed 2/23/24) · 10-K FY2022 (filed 2/24/23) · 10-K FY2021 (filed 2/25/22) · 10-K FY2020 (filed 2/22/21) · 10-K FY2019 (filed 2/21/20) · 10-K FY2018 (filed 2/26/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.